Home » Archive by Category

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

Histogen forms cancer joint venture

July 10, 2014 – 5:12 pm | Edit Post

San Diego developer of a hair loss treatment from stem cells moves into oncology.

Stem cell heart failure treatment advances

July 10, 2014 – 4:48 pm | Edit Post

Heart failure patients will get stem cell therapy from San Diego’s CardioCell.

Kristiina Vuori joins WebMD Board of Directors

July 10, 2014 – 1:55 pm | Edit Post

Sanford-Burnham’s President and Interim CEO Kristiina Vuori, M.D., Ph.D., recently joined WebMD’s Board of Directors.

West Coast Biotech Roundup: Scripps, Trounson, Versant, Gilead, & More

July 10, 2014 – 10:32 am | Edit Post
West Coast Biotech Roundup: Scripps, Trounson, Versant, Gilead, & More

The big news out west this week revolves around institutional drama. In San Diego, the faculty at The Scripps Research Institute has taken issue with merger talks that the president and board have…

[[Click headline to continue reading.]]

Big Late-Stage Deals and Unicorns Drive U.S. Venture Activity Higher

July 10, 2014 – 3:00 am | Edit Post
Big Late-Stage Deals and Unicorns Drive U.S. Venture Activity Higher

Two years ago, VC firms shrugged off sluggish economic conditions to invest $8.1 billion in 812 U.S. deals in the second quarter. It was the highest total in more than a decade—and represented…

[[Click headline to continue reading.]]

Charles E. Daniels to be Honored for His Leadership in Health-System Pharmacy

July 9, 2014 – 2:24 pm | Edit Post
Charles E. Daniels to be Honored for His Leadership in Health-System Pharmacy

The American Society of Health-System Pharmacists (ASHP) has named Charles E. Daniels, PhD, FASHP, as the recipient of the 2014 John W. Webb Lecture Award. The Webb Award honors health-system pharmacy practitioners or educators who stand…

Stem cell boss joins board he funded

July 9, 2014 – 1:37 pm | Edit Post

One week after leaving, former CIRM president Alan Trounson joins agency-funded company.

Scripps Research kills takeover by USC

July 9, 2014 – 12:31 pm | Edit Post

Faculty opposition leads board to scuttle deal with University of Southern California.

Brazil: Ready for Future Growth in Health Care

July 9, 2014 – 9:39 am | Edit Post
Brazil: Ready for Future Growth in Health Care

The eyes of the world are on Brazil. It is one of the most dynamic countries in the southern hemisphere; the sixth-largest economy in the world; and host of the World Cup, now drawing to a close. In…

[[Click headline to continue reading.]]

No extra mutations in modified stem cells, study finds

July 8, 2014 – 5:00 pm | Edit Post

LA JOLLA—The ability to switch out one gene for another in a line of living stem cells has only crossed from science fiction to reality within this decade. As with any new technology, it brings with it both promise—the hope of fixing disease-causing genes in humans, for example—as well as questions and safety concerns. Now, Salk scientists have put one of those concerns to rest: using gene-editing techniques on stem cells doesn’t increase the overall occurrence of mutations in the cells. The new results were published July 3 in the journal Cell Stem Cell.